日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma

肠道菌群和丁酸盐增强 CAR-T 细胞疗法治疗非霍奇金淋巴瘤的潜力

García-Vicente, Roberto; Rodríguez-García, Alba; Ancos-Pintado, Raquel; Arroyo, Andrés; Ortega-Hernández, Adriana; Bragado-García, Irene; Castellano, Eva; Ortiz-Ruiz, Alejandra; Navarro-Aguadero, Miguel Ángel; Modrego, Javier; Leivas, Alejandra; García-Villalba, Rocío; Tomás-Barberán, Francisco A; Sánchez-Pina, Jose María; Alonso, Rafael; Cedena, María-Teresa; Hernández-Sánchez, María; Carpio, Cecilia; Barba, Pere; Carbonell, Diego; Kwon, Mi; Bastos-Oreiro, Mariana; Martín García-Sancho, Alejandro; Jiménez-Ubieto, Ana; Valeri, Antonio; Gómez-Garre, Dulcenombre; Martínez-López, Joaquín; Linares, María

Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO

HIV相关弥漫性大B细胞淋巴瘤患者预后评分的验证:外周血参数的价值——来自西班牙淋巴瘤研究组GELTAMO的一项研究

Huguet, Maria; Morgades, Mireia; Rivas-Delgado, Alfredo; Bastos-Oreiro, Mariana; Córdoba, Raúl; Salar, Antonio; de la Cruz-Vicente, Fátima; Alcoceba, Miguel; Ferrer-Lores, Blanca; Jiménez-Ubieto, Ana; Gutiérrez, Antonio; Infante, María; Huerga, Sofía; Abrisqueta, Pau; Cruz, David; Montalbán, Carlos; Muntañola, Ana; Villambrosia, Sonia González-de; Ribera, Josep-Maria; Navarro, José-Tomás

Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

嵌合抗原受体T细胞疗法治疗T细胞/组织细胞丰富的大B细胞淋巴瘤的疗效及疾病进展后的后续治疗策略:一项GELTAMO/GETH研究

Bastos-Oreiro, Mariana; Iacoboni, Gloria; Garcés, Víctor N; Caballero, Ana C; Martínez, Nuria; Delgado, Javier; Balaguer, Aitana; Kwon, Mi; Gonzalez de Villambrosia, Sonia; Hernani, Rafael; Jimenez-Ubieto, Ana; Bailen, Rebeca; Zaberio, Izaskun; Martín García-Sancho, Alejandro; Barba, Pere

Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI

弥漫性大B细胞淋巴瘤的实验室预后指数(LAB-PI):单次血液分析预测结果与IPI、NCCN-IPI和GELTAMO-IPI一样好。

Martin-Moro, F; Bento, L; Marquet, J; Browne-Arthur, S F; Gutierrez, A; Diaz-Lopez, A; Sanchez-Pina, J; Garcia-Vela, J A; Salar, A; Cordoba, R; Novelli, S; Rodriguez-Salazar, M J; Gonzalez De Villambrosia, S; Del Campo, R; Luzardo, H D; Garcia, D; Garcia-Marco, J A; Sancho, J M; Abrisqueta, P; Martin, A; Grande, C; Lopez-Jimenez, J; Bastos-Oreiro, M

Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO

Tafasitab联合来那度胺作为弥漫性大B细胞淋巴瘤的挽救治疗:来自GELTAMO的真实世界经验

Gutierrez, Antonio; Zeberio, Izaskun; Peñalver, Francisco Javier; Martinez-Barranco, Pilar; Perez, Sandra; Morillo, Daniel; Martin, Xabier; Nicolas, Concepcion; Ferrero, Ainara; Jimenez-Ubieto, Ana; Bastos-Oreiro, Mariana; Davila-Valls, Julio; Calle, Maria Victoria; Perez, María; Rodriguez, Guillermo; Alonso, Aranzazu; Garcia-Noblejas, Ana; Sanchez Argüello, Diana; Knight, Teresa; Fernandez, Ángeles; Lopez, Javier; Perez De Oteyza, Jaime; González de Villambrosia, Sonia; Perez, Elena; Marin, Alejandro; Navarro, Maria Belen; Fernandez, Ruben; Gomez, Pilar; Hueso, José Antonio; Peñarrubia Ponce, Maria Jesus; Bravo, Pilar; Garcia-Belmonte, Daniel; De La Nuez, Haridian; Nistal, Sara; Abrisqueta, Pau; Ibañez, Fernanda; Palomera, Luis; Donato, Eva; Provencio, Andrea; Infante, Maria Stefania; Gonzalez-Barca, Eva

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

在既往未接受治疗的弥漫性大B细胞淋巴瘤(DLBCL)患者中,Mosunetuzumab联合Pola-CHP方案与Pola-R-CHP方案的比较:一项2期研究的最终结果

Westin, Jason; Phillips, Tycel J; Mehta, Amitkumar; Hoffmann, Marc S; Gonzalez-Barca, Eva; Thieblemont, Catherine; Bastos-Oreiro, Mariana; Greil, Richard; Giebel, Sebastian; Wei, Michael C; Wang, Jue; Bucher, Reinhard; Sit, Jason; Penuel, Elicia; Purev, Enkhtsetseg; Yee, Donald L; Bergua-Burgues, Juan Miguel

Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment

针对接受三线或后续治疗后出现CAR-T治疗进展的大B细胞淋巴瘤患者,开发并验证CAR-T治疗后预后指数。

Iacoboni, Gloria; Navarro, Víctor; Sesques, Pierre; Rejeski, Kai; Bastos-Oreiro, Mariana; Serpenti, Fabio; Martin Lopez, Ana Africa; Iraola-Truchuelo, Josu; Delgado, Javier; Perez, Ariadna; Guerreiro, Manuel; Caballero, Ana Carolina; Martinez-Cibrian, Nuria; Luzardo Henriquez, Hugo; Sanchez Pina, Jose Maria; Sancho, Juan-Manuel; Ghesquieres, Hervé; Mussetti, Alberto; Lopez Corral, Lucia; Hernani, Rafael; Reguera, Juan Luis; Sureda, Anna; Bosch, Francesc; Martin Garcia-Sancho, Alejandro; Kwon, Mi; Subklewe, Marion; Kuhnl, Andrea; Bachy, Emmanuel; Barba, Pere; Villacampa, Guillermo; Abrisqueta, Pau

New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

针对复发或难治性侵袭性B细胞淋巴瘤的新疗法可提高生存率:来自GELTAMO研究组RELINF注册研究的分析

Bastos-Oreiro, Mariana; Abrisqueta, Pau; Gutierrez, Antonio; Jiménez Ubieto, Ana; Poza, Maria; Fernanez-Caldas, Paula; LLacer, María José; Gonzalez de Villambrosia, Sonia; Córdoba, Raúl; López, Alberto; Ceballos, Elena; Navarro, Belen; Muntañola, Ana; Donato, Eva; Diez-Baeza, Eva; Escoda, Lourdes; Luzardo, Hugo; Peñarrubia, María José; García Belmonte, Daniel; Pardal, Emilia; Lozada, Claudia; Martín García-Sancho, Alejandro

Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

人类免疫缺陷病毒相关淋巴瘤:EHA-ESMO 临床实践指南(诊断、治疗和随访)

Hübel, Kai; Bower, Mark; Aurer, Igor; Bastos-Oreiro, Mariana; Besson, Caroline; Brunnberg, Uta; Cattaneo, Chiara; Collins, Simon; Cwynarski, Kate; Pria, Alessia D; Hentrich, Marcus; Hoffmann, Christian; Kersten, Marie J; Montoto, Silvia; Navarro, Jose-Tomas; Oksenhendler, Eric; Re, Alessandro; Ribera, Josep-Maria; Schommers, Philipp; von Tresckow, Bastian; Buske, Christian; Dreyling, Martin; Davies, Andy

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

CAR-T 疗法是药物还是治疗途径?基于意向性治疗分析与符合方案分析的 CAR-T 细胞疗法在复发难治性弥漫性大 B 细胞淋巴瘤真实世界研究中的比较

Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick L; Jain, Michael; Voorhees, Timothy J; Kittai, Adam S; Bastos-Oreiro, Mariana; Gutiérrez, Antonio; Martin Garcia-Sancho, Alejandro; Terol, Maria Jose; Mead, Monica; Maranzano, Michael J; Iacoboni, Gloria; Barba, Pere; Kwon, Mi; Bailen, Rebeca; Reguera-Ortega, Juan Luis; Mian, Agrima; Hill, Brian; Bachy, Emmanuel; Morschhauser, Franck; Houot, Roch; Thieblemont, Catherine; Le Gouill, Steven; Masetti, Riccardo; Gori, Davide; Broccoli, Alessandro; Zinzani, Pier Luigi; Argnani, Lisa